ArticleClinical Medicine Insights. Oncology2025
Effectiveness of Second-Line Pembrolizumab Monotherapy for the Treatment of Nonsmall Cell Lung Cancer: A Retrospective-Single Institution Study of 52 Vietnamese Patients.
Van Tai Nguyen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.